Search

Search Results

1. Refined risk stratification, current treatment, and new therapeutic approaches in pulmonary arterial hypertension

   The 2022 European Society of Cardiology/European Respiratory Society (ESC/ERS) guidelines for pulmonary hypertension have introduced a refined risk...

   Tobias J. Lange in Herz

   Article 21 April 2023

2. Management of the peri-intubation period in patients with pulmonary arterial hypertension and respiratory failure

   Purpose of Review

   The endotracheal intubation of patients with pulmonary arterial hypertension (PAH) in respiratory distress is a highly morbid...

   Alexander I. Papolos, Benjamin B. Kenigsberg, ... Christopher F. Barnett in Current Cardiology Reports

   Article 24 June 2024
   

3. Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?

   Pulmonary arterial hypertension (PAH) is a progressive disease that despite advances in therapy is associated with a 7-year survival of approximately...

   Ayedh K. Alamri, Christy L. Ma, John J. Ryan in Drugs

   Article 05 April 2023
   

4. A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension

   Background

   Pulmonary arterial hypertension (PAH) is a progressive, cureless disease, characterized by increased pulmonary vascular resistance and...

   Omnia Azmy Nabeh, Alaa I. Saud, ... Soha Aly Elmorsy in American Journal of Cardiovascular Drugs

   Article Open access 09 November 2023
   

5. Notch ratio in pulmonary flow predicts long-term survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

   Background

   Assessment of the pattern of the RV outflow tract Doppler provides insights into the hemodynamics of chronic thromboembolic pulmonary...

   M. A. M. Beijk, J. A. Winkelman, ... B. J. Bouma in Heart and Vessels

   Article Open access 05 June 2024
   

6. Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension

   Background

   Abnormal remodeling of distal pulmonary arteries in patients with pulmonary arterial hypertension (PAH) leads to progressively increased...

   Li Gao, John Skinner, ... Roger A. Johns in Respiratory Research

   Article Open access 06 June 2024
   

7. Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes

   Background

   Pulmonary hypertension (PH) is a common complication in patients with chronic obstructive pulmonary disease (COPD) and is closely...

   Lixia Wang, Fa** Wang, ... Fengming Luo in BMC Pulmonary Medicine

   Article Open access 18 April 2023
   

8. Spontaneous hemodynamic improvement after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension is observed within a short term after balloon pulmonary angioplasty

   Natural hemodynamic changes after balloon pulmonary artery angioplasty (BPA) in a unified state without oxygen administration in patients with...

   Shinya Fujii, Shinya Nagayoshi, ... Michihiro Yoshimura in Cardiovascular Intervention and Therapeutics

   Article 08 February 2024
   

9. Inhibition of PCSK9 Improves the Development of Pulmonary Arterial Hypertension Via Down-Regulating Notch3 Expression

   Background

   Pulmonary arterial hypertension (PAH) is a fatal disease characterized by continuous constriction and occlusion of small pulmonary...

   Peng Ye, **ao-Min Jiang, ... Juan Zhang in Cardiovascular Drugs and Therapy

   Article 31 May 2023
   

10. The Role of Lung Ventilation/Perfusion Scan in the Management of Chronic Thromboembolic Pulmonary Hypertension

    Chronic thromboembolic pulmonary hypertension (CTEPH), which is classified as a group 4 pulmonary hypertension (PH), is a life-threatening...

    Se** Ha, Sangwon Han in Nuclear Medicine and Molecular Imaging

    Article 22 November 2023
    

11. Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH)

    Background

    The aim of this study was to assess health care resource utilization (HRU) and costs associated with delayed pulmonary arterial...

    Hilary M. DuBrock, Hayley D. Germack, ... Robert P. Frantz in PharmacoEconomics - Open

    Article Open access 18 November 2023
    

12. Chronic Thromboembolic Pulmonary Hypertension

    Chronic thromboembolic pulmonary hypertension (CTEPH), defined as precapillary pulmonary hypertension (PH) by right heart catheterization and imaging...

    Krittika Teerapuncharoen, Remzi Bag in Lung

    Article 29 May 2022
    

13. Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension

    Introduction

    Ralinepag is a potent, titratable, orally administered prostacyclin (IP) receptor agonist to treat pulmonary arterial hypertension. A...

    Joan Barberà, Pavel Jansa, ... Namita Sood in Advances in Therapy

    Article Open access 10 January 2024
    

14. The Prevalence of Pulmonary Arterial Hypertension in Patients with Beta Thalassemia Major

    Pulmonary arterial hypertension (PAH) remains a concern in patients with Beta thalassemia major (TM). However, this study aims to investigate the...

    Masoumeh Kahnoji, Saeid Bitaraf, ... Hamidreza Esmaeili-Nadimi in Indian Journal of Hematology and Blood Transfusion

    Article 08 July 2023

15. Semi-Quantitative Analysis of Lung Perfusion SPECT/CT for Evaluation of Response to Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension

    Purpose

    We aimed to investigate the response to balloon pulmonary angioplasty (BPA) in chronic thromboembolic pulmonary hypertension (CTEPH) using...

    Shin Ae Han, Sangwon Han, ... Dae Hyuk Moon in Nuclear Medicine and Molecular Imaging

    Article 22 March 2024
    

16. The management pattern and outcomes of chronic thromboembolic pulmonary hypertension: rationale and design for a Chinese real-world study

    Background

    Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive pulmonary vascular disorder with substantial morbidity and...

    Shuai Zhang, Yishan Li, ... Chen Wang in BMC Pulmonary Medicine

    Article Open access 03 June 2024
    

17. Even non-expert radiologists report chronic thromboembolic pulmonary hypertension (CTEPH) on CT pulmonary angiography with high sensitivity and almost perfect agreement

    Objectives

    To assess the diagnostic performance and interobserver agreement of CT pulmonary angiography (CTPA) in the detection of chronic...

    Jan Hrdlicka, Martin Jurka, ... Lukas Lambert in European Radiology

    Article 22 August 2023
    

18. Hughes-Stovin syndrome—An important differential diagnosis in patients with suspected chronic thromboembolic pulmonary hypertension

    Hughes-Stovin syndrome (HSS) is a rare vasculitis of unknown etiology. The disease is characterized by pronounced inflammation and damage to the...

    Svitlana Pochepnia, Irene M. Lang, ... Helmut Prosch in Wiener klinische Wochenschrift

    Article Open access 15 November 2023
    

19. Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database

    Introduction

    Pulmonary hypertension (PH) is often complicated by chronic lung diseases (CLDs) such as chronic obstructive pulmonary disease (COPD) and...

    Kazuki Kitahara, Junichi Omura, ... Seok-Won Kim in Pulmonary Therapy

    Article Open access 11 November 2023
    

20. Prognostic and diagnostic utility of interleukin-6 in pediatric pulmonary arterial hypertension — a case-control study

    Pulmonary arterial hypertension (PAH) in pediatrics is a progressive disease with significant vascular remodeling, right sided heart failure, and...

    Mohamed Abdallah Abd El Megied, Mohammed Ahmed Abouelhassan, Eman Saad Abd El Salam Hadwa in European Journal of Pediatrics

    Article Open access 09 January 2024